BioLife Solutions, Inc. (NASDAQ:BLFS) had its price objective increased by Maxim Group from $7.00 to $8.00 in a report issued on Friday, Marketbeat Ratings reports. The brokerage currently has a buy rating on the medical equipment provider’s stock.

Shares of BioLife Solutions (BLFS) traded up $0.76 on Friday, hitting $5.91. The stock had a trading volume of 412,600 shares, compared to its average volume of 106,822. BioLife Solutions has a twelve month low of $1.50 and a twelve month high of $7.53.

BioLife Solutions (NASDAQ:BLFS) last issued its quarterly earnings results on Thursday, November 9th. The medical equipment provider reported ($0.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.06) by $0.03. BioLife Solutions had a negative return on equity of 49.92% and a negative net margin of 52.10%. The business had revenue of $2.96 million for the quarter, compared to analyst estimates of $2.60 million. analysts forecast that BioLife Solutions will post -0.24 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This report was published by Daily Political and is the property of of Daily Political. If you are accessing this report on another publication, it was stolen and republished in violation of international copyright & trademark laws. The original version of this report can be viewed at https://www.dailypolitical.com/2017/11/13/maxim-group-boosts-biolife-solutions-inc-blfs-price-target-to-8-00.html.

Large investors have recently added to or reduced their stakes in the business. Essex Investment Management Co. LLC acquired a new position in BioLife Solutions in the third quarter valued at about $484,000. EAM Investors LLC acquired a new position in BioLife Solutions in the third quarter valued at about $555,000. Finally, Granite Investment Partners LLC acquired a new position in BioLife Solutions in the third quarter valued at about $1,205,000. 3.27% of the stock is currently owned by hedge funds and other institutional investors.

BioLife Solutions Company Profile

BioLife Solutions, Inc (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers.

Receive News & Ratings for BioLife Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLife Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.